Trials / Withdrawn
WithdrawnNCT02757417
Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency
A Randomized Trial Comparing Intaoperative Intravenous Sodium Fluorescein to Pre-Operative Oral Phenazopyridine For Evaluation of Ureteral Patency
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University Hospitals Cleveland Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To determine the safety profile of sodium fluorescein in women undergoing cystoscopy during gynecologic surgery. To determine if either oral phenazopyridine or sodium fluorescein result in shorter cystoscopy times.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sodium fluorescein | |
| DRUG | phenazopyridine |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2018-01-01
- Completion
- 2019-12-01
- First posted
- 2016-05-02
- Last updated
- 2022-05-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02757417. Inclusion in this directory is not an endorsement.